Bahrain Approves Valneva’s COVID-19 Vaccine for Emergency Use
Alarabiya News This article reports that France’s Valneva vaccine has been granted emergency use authorization in Bahrain. Article
Read MoreAlarabiya News This article reports that France’s Valneva vaccine has been granted emergency use authorization in Bahrain. Article
Read MoreAnnals of Medicine & Surgery This article shows how a few localities in Sudan continue to have low vaccine uptake compared to target populations, particularly among the elderly and those with illnesses. Journal Article
Read MoreFrontiers in Immunology This article studies the length of stay of alpha and delta variants of COVID-19 in both vaccinated and unvaccinated individuals admitted to COVID-19 treatment facilities under the Bahrain Ministry of Health. Journal Article
Read MoreBMJ Open This article reviews the determinants of vaccine hesitancy in the MENA region, highlighting the importance of geographic, cultural and religious factors. Journal Article
Read MoreVaccines This article studies the knowledge and perception of Jordan’s healthcare workers of the COVID-19 vaccine. Findings show that physicians were more likely to take the vaccine due to their higher knowledge of its components, side effects, and other aspects. Journal Article
Read MoreUNHCR According to the United Nations High Commissioner for Refugees, more than half the refugees in Jordan aged 18+ have been vaccinated. Statistics reveal that 90% of adult refugees in Al Zaatari and Al Azraq camps have at least received one dose of Covid-19 vaccination. Article
Read MoreAnnals of Medicine and Surgery This study examines the reasons behind vaccine hesitation among Syrians. It shows that citizens especially in rural areas are reluctant to receive the vaccine due to countless factors including the vaccine’s side effects, the country’s conflict, and displacement. Journal Article
Read MoreCNBC Arabia Morocco has opened today in the presence of King Mohammed the Sixth a factory to produce corona vaccination with investments reaching up to 400 and 500 million Euros. Article
Read MoreDrugs and Therapy Perspectives This article reveals the nature and classification of reported adverse drug reactions of the two COVID-19 vaccines (tozinameran and ChAdOx1) among citizens and residents living in Saudi Arabia. It shows possible differences between the two vaccines. The study found that the frequencies of most listed ADRs were statistically different when seven…
Read MoreWorld Bank This World Bank feature acknowledges that Mauritania has been one of the leading countries in Africa in championing COVID-19 vaccination with more than 40% of the adult population being fully vaccinated. It also lists the key drivers for the success of Mauritania’s vaccine roll-out. Article
Read More